News

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
Eight individuals, including employees from Dr Reddy's Lab, have been arrested for stealing Semaglutide powder worth over Rs.
A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...
Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...
Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro might not work as well as advertised, a bombshell study from ...
Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...
Ozempic is a medication primarily approved for managing type 2 diabetes. Its active ingredient, semaglutide, mimics a hormone ...
Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...
Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...
A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...